Degradation is a therapeutic strategy that could offer possibilities to get at currently undruggable target proteins. In ...

Finding they were “arbitrary and capricious” under the Administrative Procedures Act, the District Court for the District of Columbia vacated a White House Office of Personnel Management memo and a ...

Boston Scientific Corp. gained a second U.S. FDA approval for its Farapulse pulsed field ablation catheter, expanding its use into drug-refractory, symptomatic persistent atrial fibrillation (AF) in ...

After delaying a June PDUFA date, the U.S. FDA has approved Kalvista Pharmaceuticals Inc.’s Ekterly (sebetralstat) for hereditary angioedema (HAE) in those aged 12 and older. The plasma kallikrein ...

A recent study published in the Journal for Immunotherapy of Cancer has revealed a promising new approach for the treatment ...

Field Medical Inc. continues to reap funding from investors for its pulsed field ablation (PFA) system with a $35 million ...

The first systematic whole genome sequencing study of how chemotherapy damages healthy tissues has shown that many, but not ...

The oxidase, cytochrome c, assembly 1-like (OXA1L) gene plays a key role in inserting and assembling proteins in the inner ...

Researchers at Washington University reported the preclinical validation of [18F]FQ-NeuroROS, a redox-sensitive reporter ...

Chinese investigators have published data from studies investigating CYT-997 for the treatment of hypertrophic scars. CYT-997 is a tubulin polymerization inhibitor that reached phase II clinical ...

Protagonist Therapeutics Inc. has nominated PN-477 as a development candidate for the treatment of obesity. Copyright ©2025.

All kinds of substances circulate through the bloodstream. Some are beneficial, like oxygen or nutrients, and others less so, ...